Who will renew the KEY hydroxychloroquine

The world health organization intends to resume clinical investigation of anti-malarial drug hydroxychloroquine as a means of therapy COVID-19. A study conducted by who was suspended for security reasons in may of this year after patients treated with hydroxychloroquine, was recorded an increased mortality rate and complications associated with cardiac arrhythmias.

However, during the online conference held on Wednesday in the United States, who Director-General Tedros Aden Gebreyesus said that experts from the international organization recommend to finish all the investigation of potential means of treatment of coronavirus infection, including antimalarial drugs.

The decision of the who, adopted in may, influenced the course of other KEY hydroxychloroquine. In particular, at the end of may on the suspension of recruitment of volunteers for their own studies of the drug, said the company Sanofi.

Deputy Director General of who Sumia Swaminathan (Swaminathan Soumya) said that all studies of the drug should continue. “Our commitment to our patients is to get a definite answer, it works this medicine”, she explained.

Swaminathan also announced the intention of the who to see the results of clinical studies of the drug Aviewer (favipiravir), which was recently approved for use as treatment COVID-19 in Russia.

Leave a Reply

Your email address will not be published. Required fields are marked *


For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]